Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cook

Showing results (1641-1650 of 1,674) with videos related to

Pageof 168
Sort By:
The Lancet. Oncology|June 11, 2022
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trialAndrew R Clamp, Elizabeth C James, Iain A McNeish, et al.
Nature|December 2, 2005
Rain, winds and haze during the Huygens probe's descent to Titan's surfaceM G Tomasko, B Archinal, T Becker, et al.
New Directions for Child and Adolescent Development|September 22, 2020
Manifesto for new directions in developmental scienceBaptiste Barbot, Sascha Hein, Christopher Trentacosta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
The genome of the fire ant Solenopsis invictaYannick Wurm, John Wang, Oksana Riba-Grognuz, et al.
Scientific Reports|March 16, 2018
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology StudiesCollin D Edington, Wen Li Kelly Chen, Emily Geishecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2021
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE TrialHannah L Rush, Laura Murphy, Alicia K Morgans, et al.
JAMA|December 11, 2008
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Eric A Klein, Phyllis J Goodman, et al.
Science (New York, N.Y.)|January 29, 2026
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapyJunedh M Amrute, In-Hyuk Jung, Tracy Yamawaki, et al.
Lancet (London, England)|May 19, 2024
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trialChris C Parker, Howard Kynaston, Adrian D Cook, et al.
Lancet (London, England)|May 19, 2024
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trialChris C Parker, Noel W Clarke, Adrian D Cook, et al.
Pageof 168

Showing results (1641-1650 of 1,674) with videos related to

Sort By:
Pageof 168
The Lancet. Oncology|June 11, 2022
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trialAndrew R Clamp, Elizabeth C James, Iain A McNeish, et al.
Nature|December 2, 2005
Rain, winds and haze during the Huygens probe's descent to Titan's surfaceM G Tomasko, B Archinal, T Becker, et al.
New Directions for Child and Adolescent Development|September 22, 2020
Manifesto for new directions in developmental scienceBaptiste Barbot, Sascha Hein, Christopher Trentacosta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
The genome of the fire ant Solenopsis invictaYannick Wurm, John Wang, Oksana Riba-Grognuz, et al.
Scientific Reports|March 16, 2018
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology StudiesCollin D Edington, Wen Li Kelly Chen, Emily Geishecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2021
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE TrialHannah L Rush, Laura Murphy, Alicia K Morgans, et al.
JAMA|December 11, 2008
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Eric A Klein, Phyllis J Goodman, et al.
Science (New York, N.Y.)|January 29, 2026
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapyJunedh M Amrute, In-Hyuk Jung, Tracy Yamawaki, et al.
Lancet (London, England)|May 19, 2024
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trialChris C Parker, Howard Kynaston, Adrian D Cook, et al.
Lancet (London, England)|May 19, 2024
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trialChris C Parker, Noel W Clarke, Adrian D Cook, et al.
Pageof 168